Document is current

Any future updates will be listed below

Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma

Crossref DOI link: https://doi.org/10.1245/s10434-023-14252-2

Published Online: 2023-09-03

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark